COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
NCT06297876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-12-04
Summary
Pilot randomized controlled trial testing the investigator's previously developed storytelling method to create an interactive, multi-media storytelling intervention to address community-identified reasons for vaccine hesitancy among Black and Hispanic individuals in Central Massachusetts
Conditions
- Vaccine Hesitancy
Interventions
- BEHAVIORAL
-
Storytelling
Narrative stories will be videos that are 2-3 minutes long and will show community members speaking based on community identified themes.
- BEHAVIORAL
-
Learn More (Active Comparator)
Informational videos that are of similar length and on the same topic as the storytelling videos.
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Massachusetts, Worcester
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 105 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-19
- Primary Completion
- 2024-08-09
- Completion
- 2024-08-09
Countries
- United States
Study Locations
More Related Trials
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom
NCT03632720 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
NCT04689191 ·Status: UNKNOWN ·Phase: PHASE3
-
A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil
NCT05403307 ·Status: COMPLETED
-
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT06603090 ·Status: COMPLETED ·Phase: NA
-
Improving the School Vaccination Experience: What CARDs Are You Going to Play?
NCT03966300 ·Status: TERMINATED ·Phase: NA
-
Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
NCT05107557 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of the Booster Dose of Two MenC Vaccines
NCT00392808 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis
NCT01482052 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
NCT00667602 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
NCT03014089 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
NCT03537508 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
NCT00384397 ·Status: COMPLETED ·Phase: PHASE3
-
MenB Vaccine: Implementation Via Information, Empowerment and Accessibility
NCT02975596 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose
NCT05367895 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico
NCT03630705 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme
NCT04930185 ·Status: UNKNOWN ·Phase: NA
-
Screening for Hesitancy to Optimize Talk
NCT02708745 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612
NCT00955682 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
NCT01897402 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers
NCT00422292 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
NCT03691610 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months
NCT05229536 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers
NCT00387569 ·Status: COMPLETED ·Phase: PHASE1
-
Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants
NCT03765073 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19
NCT07222384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3